Terminated PHASE3 INTERVENTIONAL 2-arm NCT00954603

A Double-blind, Randomized, Controlled Trial of Quetiapine Versus Haloperidol for the Treatment of Delirium (QHdelirium)

Compare Efficacy and Safety Between Quetiapine and Haloperidol in Treatment Delirium

Sponsor: Chiang Mai University

Conditions Delirium

Updated 6 times since 2017 Last updated: Jun 22, 2011 Started: Jun 30, 2009 Primary completion: Apr 30, 2011 Completion: Jul 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

few delirious patients were enrolled.

This PHASE3 trial investigates Delirium and is currently terminated or withdrawn. Chiang Mai University leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Terminated PHASE3
Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chiang Mai University

Data source: Chiang Mai University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chiang Mai, Thailand